TAK-701

· Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-701, covering 2011-12-02 to 2011-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies [Phase 1]